INTEGRA LIFESCIENCES HOLDINGS CORP Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Integra Lifesciences Holdings Corp quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
  • Integra Lifesciences Holdings Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.15M, a 131% decline year-over-year.
  • Integra Lifesciences Holdings Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was $28.8M, a 79.9% decline year-over-year.
  • Integra Lifesciences Holdings Corp annual Operating Income (Loss) for 2023 was $112M, a 53.3% decline from 2022.
  • Integra Lifesciences Holdings Corp annual Operating Income (Loss) for 2022 was $239M, a 21.1% increase from 2021.
  • Integra Lifesciences Holdings Corp annual Operating Income (Loss) for 2021 was $197M, a 30.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $28.8M -$8.15M -$34.7M -131% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $63.6M -$3.03M -$15.5M -124% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-29
Q1 2024 $79.1M $3.96M -$32.4M -89.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $112M $36M -$31.8M -46.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $143M $26.6M -$38.5M -59.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $182M $12.5M -$47.4M -79.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-29
Q1 2023 $229M $36.4M -$9.78M -21.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $239M $67.8M +$9.62M +16.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $229M $65M +$8.61M +15.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-25
Q2 2022 $221M $59.9M +$8.01M +15.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $213M $46.2M +$15.5M +50.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q4 2021 $197M $58.2M +$5.58M +10.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $192M $56.4M -$1.1M -1.92% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 $193M $51.9M +$37.8M +268% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 $155M $30.7M +$3.61M +13.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q4 2020 $151M $52.6M +$16.6M +45.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $135M $57.5M +$78.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $56.7M $14.1M -$31.9M -69.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $88.6M $27.1M -$5.21M -16.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $93.8M $36.1M +$1.97M +5.78% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $91.8M -$20.6M -$44.3M -187% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $136M $46M +$18.3M +66.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $118M $32.3M +$6.73M +26.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $111M $34.1M +$26.9M +373% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 $84.1M $23.7M +$13M +122% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-25
Q2 2018 $71.1M $27.6M +$10.6M +62.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-25
Q1 2018 $60.4M $25.6M +$15.6M +157% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 $44.8M $7.22M -$33.6M -82.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $78.4M $10.6M -$19.5M -64.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $97.8M $17M -$5.39M -24.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-26
Q1 2017 $103M $9.96M -$12.1M -54.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-26
Q4 2016 $115M $40.8M +$16.8M +69.8% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $98.6M $30.1M +$20.1M +201% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $78.5M $22.4M -$1.97M -8.08% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $80.4M $22.1M +$860K +4.05% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q4 2015 $79.6M $24M -$5.61M -18.9% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $85.2M $9.99M -$7.11M -41.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $92.3M $24.3M +$12M +96.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $80.4M $21.2M +$12.5M +143% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-27
Q4 2014 $67.9M $29.6M -$33.5M -53.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 $101M $17.1M +$48.2M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $53.1M $12.4M +$6.84M +123% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-31
Q1 2014 $46.3M $8.74M +$10.9M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-01
Q4 2013 $35.4M $63.1M +$44.6M +240% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 -$9.22M -$31.1M -$50.9M -258% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $41.7M $5.56M -$12.5M -69.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $54.1M -$2.19M -$19.7M -113% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 $73.8M $18.6M +$10.8M +139% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $63M $19.7M +$1.45M +7.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-30
Q2 2012 $61.5M $18M +$10M +125% Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-08-02
Q1 2012 $51.5M $17.5M -$3.41M -16.3% Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-08-02
Q4 2011 $54.9M $7.75M -$16.4M -67.9% Oct 1, 2011 Dec 31, 2011 8-K 2014-06-20
Q3 2011 $71.3M $18.3M -$9.02M -33% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-24
Q2 2011 $80.3M $8M -$16.6M -67.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-31
Q1 2011 $96.9M $20.9M -$1.77M -7.82% Jan 1, 2011 Mar 31, 2011 10-Q 2012-07-31
Q4 2010 $98.7M $24.2M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 $27.3M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $24.6M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-01
Q1 2010 $22.6M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.